Rua Life Sciences PLC

RUA Life Sciences plc develops medical devices through its subsidiaries across Europe, North America, the Middle East, Asia Pacific, and Africa. It operates in four segments: Biomaterials, Contract Manufacture, Vascular, and Structural Heart. The company holds intellectual property and licensing rights to biostable and implantable polymers, including Elast-Eon and ECSil, and provides sub-contract manufacturing, assembly, packing, and related services for medical devices and implantable fabric. It also develops and commercializes bore polymer sealed grafts and soft tissue patches, and is developing tri-leaflet polymeric heart valves. Formerly known as AorTech International plc, it changed its name to RUA Life Sciences plc in June 2020. The company was incorporated in 1996 and is headquartered in Irvine, the United Kingdom.